One such medication is the opioid
antagonist naltrexone, which has been approved for treatment of alcohol dependence by the Food and Drug Administration.
Not exact matches
Researchers at the Norwegian Centre for Addiction Research (SERAF) in Oslo are examining sustained - release
naltrexone — a non-addictive opioid
antagonist that blocks the effects of opiates in the brain.
Low dose
Naltrexone and ALA (alpha lipoic acid)--
Naltrexone is an opioid
antagonist and if taken at night it will block the opioid receptors for a few hours.
It is followed by administration of
naltrexone an opioid
antagonist.